3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
981
INDUSTRY
358
NIH
87
OTHER_GOV
22
NETWORK
20
INDIV
1
FED
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Gastrointestinal
1
Conditions
Neoplasms
4
Leiomyoma
3
Lung Neoplasms
2
Lipoma
2
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Barrett Esophagus
2
Uterine Neoplasms
1
Urinary Bladder Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Overweight
1
Osteosarcoma
1
Obesity
1
Neutropenia
1
Neoplasms, Squamous Cell
1
Melanoma
1
Lymphoma, Follicular
1
Lymphoma
1
Liver Neoplasms
1
Leiomyomatosis
1
Inflammatory Bowel Diseases
1
Hypotrichosis
1
Fibrosis
1
Craniopharyngioma
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma in Situ
1
Cancer Cachexia
1
Interventions
sargramostim
1
pembrolizumab
1
Ipilimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
INDIV
×
Pancreatic Neoplasms
×
Clear all
NCT03695835
2020-07-22
NIRPA
Gary Onik MD
Completed
27 enrolled